Hyperthermia
Pump

The Hyperthermia Pump raises the temperature of a patient’s thoracic or peritoneal cavity to the desired target temperature by continuously lavaging it with warmed sterile solution.

Description

Description

The highly efficient Hyperthermia Pump™ is used in therapeutic procedures to raise the temperature of the thoracic or intraperitoneal cavity to the desired target temperature through continuous lavage with warmed sterile solution. The warmed solution is pumped into a body cavity, withdrawn, reheated, and recirculated back to the body. User friendly, compact, and safe, the Hyperthermia Pump is a global leader in delivery of hyperthermia therapy.

Key Features:
1.Highly Efficient Inductive Heat
2.Precise Temperature Control
3.Purpose-built for Patient Safety
4.Compact Design

Download Product Brochure

Specifications

Specifications

Code

902-00001

Dimensions

34.29 x 30.48 x 19.05 (cm)

Net Weight

28.5 lbs (13.0 Kg)

Portability

Hand Carry: Handle on top of unit for easy transport
I.V Pole Mount: I.V pole mountable or free standing. I.V pole diameter range of pole mount: 1" - 1 1/4"

Power(AC)

115-120 V~ 20 amp dedicated or 230 V~ 16 amp dedicated

Power(Battery)

Battery Type: Rechargeable lead acid
Running Time: Very short time without heat
Recharge Time: 8 hours

Environmental

Operating Temperature: 10°C~32°C (50°F~90°F)
Storage Temperature: -15°C~40°C
Relative Humidity: 10%~90%
Pressure: 49~103 kPa

Flow Rate

10~1000 ml/min
Tolerance: 10% from 20 - 1000 ml/min, 25% for 10 ml/min

Output Temperature

37~48°C

Heating Capacity

Min. 1400 watts to fluid (20°C temperature rise at 1000 ml/min)

Line Pressure

0~300 mmHg

Control Panel

Control Panel and Display: Splash proof touch screen display
Display Area: Diagonal screen 5.7” (14.5 cm)
Status Display:
1.Flow rate (ml/min)
2.Total volume infused (ml)
3.Line pressure (mmhg)
4.Output fluid temperature(°C)
5.Patient temperature(T1 - T4)(°C)
6.Target temperature(°C)
7.Alarm messages

Safety and Monitoring

1.Infusate Temperature: Via infra-red sensors at the input and output to the heat exchanger.
2.Line Pressure: A pressure transducer monitors the in line pressure. If the pressure reaches the threshold set by the user, the pump will slow down until pressure falls below the threshold. If the in-line pressure rises faster than 40 mm Hg/ml or exceeds 400 mm Hg, audible alarm sounds, the "HIGH PRESSURE" message is displayed, the line to the patient is closed and pump comes to an immediate stop.
3.Air Detection: Two ultrasonic air detectors monitor air in the fluid path. The fluid detector is mounted closest the fluid bag. It sounds an alarm if there is no fluid entering the system. The other air detector checks for air in the fluid line before it enters the patient line.
4.Valve wand: Provides flow path to patient, or recirculation fluid path within the system. The recirculation path is used to prime the system and eliminate air after an air detection alarm. The recirculation path is activated at all alarm conditions.

References

References

1.Riley, W. “Belmont™ Hyperthermia Pump in the Conduct of Intra-Operative Heated Chemotherapy.” Perfusion, vol. 24, no. 2, Mar. 2009, pp. 115–118, doi:10.1177/0267659109106815.
文章闡述波士頓布萊根婦女醫院(Brigham and Women’s Hospital)胸腔外科使用胸膜外全肺切除術(Extrapleural pneumonectomy)、胸膜切除術(pleurectomy)並搭配使用Belmont Hyperthermia Pump作為肋膜間皮瘤(Mesothelioma)的一種治療選項。
前往文章

2.Paul H. Sugarbaker, O. Anthony Stuart, and Christopher Eger, “Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication,” Gastroenterology Research and Practice, vol. 2012, Article ID 471205, 4 pages, 2012.
文章闡述胸膜切除術(Pleurectomy)及胸膜剝除術(Decortication)結合胸腔溫熱化療的藥物動力學,文章中的研究方法(Materials and Methods)提及Belmont Hyperthermia Pump於其中的運用。
前往文章

3.Kim DW, Park DG, Song S, Jee YS.   Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy as Treatment Options for Peritoneal Metastasis of Advanced Gastric Cancer.   J Gastric Cancer. 2018 Sep;18(3):296-304.   https://doi.org/10.5230/jgc.2018.18.e32
文章探討腫瘤減量手術(Cytoreductive Surgery)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)作為胃癌腹膜轉移患者的一種治療選項。在文章的研究方法(Materials and Methods)方面說明到Belmont Hyperthermia Pump於其中的搭配使用方法。
前往文章

4.Brown, Zachary J et al. “Heated intraperitoneal chemotherapy and gastrectomy for gastric cancer in the U.S.: the time is now.” Journal of gastrointestinal oncology 8,6 (2017): 1109-1113. doi:10.21037/jgo.2017.09.01
文章探討使用胃切除術(Gastrectomy)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)對於美國胃癌患者的作用。文章內的研究方法(Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

5.Arslan, Naciye Cigdem & Bisgin, Tayfun & Altay, Canan & Yavuzsen, Tugba & Karaoglu, Aziz & Canda, Aras & Sarioglu, Sulen & Sokmen, Selman. (2018). Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?. Journal of B.U.ON.: official journal of the Balkan Union of Oncology. 23. 77-83.
文章探討使用腫瘤減量手術(Cytoreductive Surgery)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)是否適用於高齡(> 65 years)大腸癌腹膜轉移患者。文章內的研究方法(Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

6.Somashekhar, S.P.; Prasanna, G.; Jaka, R.; Rauthan, A.; Murthy, H.S.; Karanth, S. Hyperthermia Intraperitoneal chemotherapy for peritoneal surface malignancies: A single institution Indian experience. Natl. Med. J. India 2016, 29, 262-266.
文章探討腫瘤減量手術(Cytoreductive Surgery)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)在印度作為腹膜表面惡性腫瘤的一種治療方式的成效與適用性。文章內的研究方法(Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

7.Teo, Melissa Ching Ching et al. “Colorectal peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: the experience of a tertiary Asian center.” Asian journal of surgery 38 2 (2015): 65-73 .
文章探討腫瘤減量手術(Cytoreductive Surgery)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)在新加坡作為大腸癌腹膜轉移患者的一種治療方式的成效與經驗分享。文章內的研究方法(Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

8.Park, Eun Jung et al. “Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colorectal cancer with peritoneal carcinomatosis: Clinical outcomes at 2 tertiary referral centers in Korea.” Medicine 96,21 (): e6632. doi:10.1097/MD.0000000000006632
文章探討腫瘤減量手術(Cytoreductive Surgery)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)在韓國作為盲腸癌或大腸癌腹膜轉移患者的一種治療方式的成效與經驗分享。文章內的研究方法(Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

9.Baumgartner JM, Tobin L, Heavey SF, et al. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2015;22:1716-21.
文章探討高級數(High grade)盲腸癌或大腸癌腹膜轉移患者施行腫瘤減量手術(Cytoreductive Surgery)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)的預後因素。文章內的研究方法(Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

10.Esquivel, Jesus, and Andrew Averbach. “Laparoscopic Cytoreductive Surgery and HIPEC in Patients with Limited Pseudomyxoma Peritonei of Appendiceal Origin.” Gastroenterology research and practice 2012 (2012): 981245. doi:10.1155/2012/981245
文章探討腹腔鏡腫瘤減量手術(Laparoscopic Cytoreductive Surgery)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)作為治療起源於闌尾的腹膜假性黏液瘤(Pseudomyxoma Perutonei, PMP)的成效與經驗分享。文章內的研究方法(Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

11.Sugarbaker, Paul H et al. “Intraperitoneal gemcitabine chemotherapy treatment for patients with resected pancreatic cancer: rationale and report of early data.” International journal of surgical oncology 2011 (2011): 161862. doi:10.1155/2011/161862
文章探討腹腔內化療作為胰臟癌切除患者的治療成效與經驗分享。文章內的研究方法(Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

12.Kim, Woo Ram et al. “Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy.” Annals of coloproctology 33,1 (2017): 16-22. doi:10.3393/ac.2017.33.1.16
文章探討腫瘤減量手術(Cytoreductive Surgery)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)在韓國作為腹膜假性黏液瘤(Pseudomyxoma Perutonei, PMP)或腹膜轉移癌(Peritoneal Carinomatosis, PC)的一種治療方式的成效與經驗分享。文章內的研究方法(Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

13.Aksel, Bülent & Şahin, Hanifi & Sarı, Mustafa Erkan. (2018). The Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Malignant Peritoneal Mesothelioma: A Tertiary Center Experience. International Journal of Hematology and Oncology. 28. 10.4999/uhod.182308.
文章探討腫瘤減量手術(Cytoreductive Surgery)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)在土耳其作為惡性腹膜間皮瘤(Malignant Peritoneal Mesothelioma, MPM)的一種治療方式的成效與經驗分享。文章內的研究方法(Patients and Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

14.Teo, Melissa Ching Ching, Claramae Shulyn Chia, Cindy Lim, et al. “Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer with peritoneal metastasis: a prospective registry study on 41 patients ” Pleura and Peritoneum, 2.4 (2017): 171-179. Retrieved 2 Jul. 2019, from doi:10.1515/pp-2017-0021
文章探討腫瘤減量手術(Cytoreductive Surgery)結合腹腔溫熱化療(Hyperthermic Intraperitoneal Chemotherapy, HIPEC)在新加坡作為復發性卵巢癌的一種治療方式的成效與經驗分享。文章內的研究方法(Materials and Methods)中提及Belmont Hyperthermia Pump於其中的運用。
前往文章

You may also like…

  • Belmont Medical

    Hyperthermia Pump Procedure Kit

    Procedure Kit Disposable for the Hyperthermia Pump.The Procedure Kit includes: Heat Exchanger, 4.4L Reservoir, Procedure Pack, Sumps, Via-Guard and Temperature probes

    • Aluminum-free
    • DEHP-free